Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Role of cGAS/STING pathway in aging and sexual dimorphism in diabetic kidney disease
Sherif Khedr, Lashodya V. Dissanayake, Ammar J. Alsheikh, Adrian Zietara, Denisha R. Spires, Romica Kerketta, Angela J. Mathison, Raul Urrutia, Oleg Palygin, Alexander Staruschenko
Sherif Khedr, Lashodya V. Dissanayake, Ammar J. Alsheikh, Adrian Zietara, Denisha R. Spires, Romica Kerketta, Angela J. Mathison, Raul Urrutia, Oleg Palygin, Alexander Staruschenko
View: Text | PDF
Research Article Nephrology

Role of cGAS/STING pathway in aging and sexual dimorphism in diabetic kidney disease

  • Text
  • PDF
Abstract

Diabetic kidney disease (DKD) is the leading cause of chronic renal pathology. Understanding the molecular underpinnings of DKD is critical to designing tailored therapeutic approaches. Here, we focused on sex differences and the contribution of aging toward the progression of DKD. To explore these questions, we utilized young (12 weeks old) and aged (approximately 50 weeks old) type 2 diabetic nephropathy (T2DN) rats. We revealed that the cyclic GMP-AMP synthase (cGAS)/stimulator of interferon genes (STING) pathway was upregulated in T2DN rats compared with nondiabetic Wistar rats and in type 2 diabetic human kidneys. The activation of the cGAS/STING signaling pathway exhibited distinct protein expression profiles between male and female T2DN rats, with these differences becoming more pronounced with aging. RNA-Seq analysis of the kidney cortex in both male and female T2DN rats, at both younger and older ages, revealed several key molecules, highlighting crucial genes within the cGAS/STING pathway. Thus, our study delved deep into understanding the intricate sexual differences in the development and progression of DKD and we propose the cGAS/STING pathway as an essential contributor to disease development.

Authors

Sherif Khedr, Lashodya V. Dissanayake, Ammar J. Alsheikh, Adrian Zietara, Denisha R. Spires, Romica Kerketta, Angela J. Mathison, Raul Urrutia, Oleg Palygin, Alexander Staruschenko

×

Figure 3

Expression analysis for TREX1, mtTFA, and cGAS/STING pathway molecules in T2DN rats of different sex and age groups.

Options: View larger image (or click on image) Download as PowerPoint
Expression analysis for TREX1, mtTFA, and cGAS/STING pathway molecules i...
(A) Western blot analysis of mtTFA and TREX1 expression levels for both sexes in young and old T2DN rats; β-actin was used as a loading control. n = 6 rats in each group. (B) Summary graphs of relative abundance of mtTFA and TREX1 shown in A. Each dot represents 1 rat. (C) Expression level of the cGAS/STING pathway proteins (cGAS, STING, p-TBK1, TBK1, p-IRF3, and IRF3) in the kidneys of both sexes in young and old T2DN rats. Each lane represents 1 rat. n = 6, except for p-IRF3 in which n = 4. (D) Summary graphs of relative abundance of cGAS/STING pathway proteins after normalization to β-actin loading control. Data shown as mean ± SEM. Statistical analysis was performed using a 2-way ANOVA test. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. NS, nonsignificant; a.u., arbitrary units. (E) IRF3 adaptor protein activator (Mavs, Trif, and Sting) levels obtained from RNA-Seq data represented as RPKM. Statistical analysis was performed using unpaired and paired 2-tailed Student’s t tests. *P < 0.05, **P < 0.1, ****P < 0.0001. (F) Type I IFN signaling pathway molecule (Ifnar1, Ifnar2, Jak1, Tyk2, Irf9, Stat1, and Stat2) levels obtained from RNA-Seq data represented as RPKM. n = 4 rats in each group. Statistical analysis was performed using unpaired and paired 2-tailed Student’s t tests. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, indicates statistically significant difference within the same genes. NS, nonsignificant.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts